More Videos- Geek Squad V. Gizmodo
- Other People Are Weirder Than We Are
- California Here I Go? No.
- Why Save Orphans When You Can Save Newspapers?
- Call Of Shame - Vote Now
- Lenny Dykstra - What Went Wrong?
- EADS: No Regrets For Tanker Try
- Jackson's Socks, Belt Buckle And Brain
- The Jackson Memorial: The Gift That Keeps Giving
- Jackson Memorial: Not Quite The Logistical "Thriller"
- Eric Schmidt on Government Scrutiny and Economic Recovery
- Market 360: The Week's Best & Worst
- Geek Squad V. Gizmodo
- Brandt: Google Chrome OS in the Post-PC Age
- Other People Are Weirder Than We Are
- Bank Failures: Is The Nightmare Over? (Video)
- California Here I Go? No.
- Roginsky: No More Mr. Nice Guy
- Commercial Conundrum
- Cheney Told CIA to Withhold Information: Report
- Why the Credit Pendulum Is Stuck at 'Stupid'
- Stimulus Will Kick in Later this Year: President Obama
- Lender CIT Group Hires Premier Bankruptcy Adviser
- Government Selling Bank Stakes for Too Cheap: Panel
- Buffett's Top 3 Investment Rules for Average Americans
- Market Insider: Earnings Loom in the Week Ahead
- Bulls Get Summertime Blues, But It's Hot Fun for Bears
- As Banks Fail, Strong Institutions Become More Visible
RSS FEED
Text Size 
 |
CNBC.com photo composite |
] disappointed the street this morning with its earnings report. Allergan is Fake Jane's favorite company. Even though earnings and sales were up double digits--sales topping a billion dollars for the first time in one quarter--the outlook is below street expectations, and an important drug trial failed. So, as blogged yesterday, Fake Jane will will be using her tax rebate to help save Allergan! She lives for the company's number one product--Botox. Sure, Botox is fighting efforts by Public Citizen to force the FDA to put warnings on Botox boxes suggesting it may have potential fatal side effects. This has not been proven, and Fake Jane doesn't really care! She's fake! Botox sales were pretty good in the fourth quarter, up 24 percent to $340 million, and up 23 percent for the year at $1.2 billion, nearly a third of the company's total income. That's a lot of shots.
Also of interest to Fake Jane is Allergan's "breast aesthetics" sector (can't we just say "implants"?). Sales here were up 38 percent for the quarter and 68 percent for the year! However, the company is only forecasting about 14 percent growth for 2008, in part because it's closing an implant facility in Ireland and moving production to Costa Rica. Well, duh. I mean, Fake Jane would much rather have a Costa Rican bust than the Irish one she inherited.
Meantime, the company reports a glaucoma drug it hoped to market failed to work better than a placebo in trials. Fake Jane will worry about glaucoma later. She's more interested in the deal the company has signed with Clinique to sell specialized skin care products.
Fake women of America... we must unite to keep these companies thriving in any economic downturn! It is better to look good than to look real. Judge for yourself with the results of Fake Jane's miraculous make-over.
 |
CNBC.com photo composite |
Comments? Funny Stories? Email
Data is a real-time snapshot *Data is delayed at least 15 minutes